Business

Endonovo Announces Distribution Agreement with Academy Medical

Endonovo Announces Distribution Agreement with Academy Medical.

articleEndonovo Therapeutics, Inc.March 6, 20233/company/endonovo-therapeutics-inc/news/endonovo-announces-distribution-agreement-with-academy-medical
Endonovo Announces Distribution Agreement with Academy Medical

About this update from Endonovo Therapeutics, Inc.

[{"type":"text","content":"\n Provide Improved Medical Services to VHA and U.S. Dept. of Defense Los Angeles, CA, March 06, 2023 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) today announced the signing of a Service-Disabled Veteran-Owned Small Business (SDVOSB) Government Reseller Agreement (Agreement or Contract) with Academy Medical, Inc. of West Palm Beach, FL to distribute SofPulse® medical devices to ensure its availability to the Veterans Health Administration (VHA) and Department of Defense (DoD) contracts. The new Contract allows Academy Medical and Endonovo to team up and bring top-notch medical and surgical supplies, as well as telehealth solutions, to our military and veterans. SofPulse® Benefits for Veterans SofPulse® Pulse Electro Magnetic Frequency (PEMF) medical devices are FDA cleared and clinically proven for the reduction of postoperative pain and edema. Endonovo’s Medical Device Division, run by Ira Weisberg President and Chief Commercial Officer, is focusing on commercializing its SofPulse® medical device line and telehealth initiatives. Weisberg has a proven track record of growing revenues and demand for similar medical device companies. Through the announced Agreement, he is expected to have similar success developing distribution for SofPulse®. This newly-signed Agreement with Academy Medical is designed to improve healthcare for both our military and veterans, better access to medical and surgical supplies and telehealth solutions that make a real impact in the lives of our heroes. The Agreement The Agreement with Endonovo focuses on developing commercialization initiatives to improve the post-operative outcomes of our military and veterans by reducing pain and edema while improving recovery times and reducing opioid use after surgery. Additionally, this Agreement allows Academy Medical to provide its expertise in the procurement process of medical and surgical supplies to enhance access to the federal medical marketplace and the distribution of SofPulse®. The result of the Agreement will offer improved access to medical and surgical supplies for veterans as well as offering veterans a non-opioid solution for postoperative pain management. Weisberg said of the announcement: “Teaming up with Academy Medical is an important step in SofPulse, Inc.’s growth and expansion...

More updates from Endonovo Therapeutics, Inc.